GlassScriptPhysician profile
Susan A Gilbert
NPI 1891981478
$1,582.76
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $134 · 2022: $911 · 2023: $510 · 2024: $28.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $538.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $256.54 | 2022-2023 | Nalu Neurostimulation System |
| Boston Scientific Corporation | $237.40 | 2022-2024 | Patient Trial Kit, Wavewriter Alpha Prime 16 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $163.86 | 2021-2023 | Relistor |
| Nevro Corp. | $151.39 | 2022 | |
| Stimwave Technologies Incorporated | $149.88 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $140.86 | 2022 | |
| Abbvie INC. | $93.69 | 2022-2023 | |
| Pfizer INC. | $88.38 | 2023 | |
| Scilex Pharmaceuticals INC. | $79.29 | 2022-2023 | Ztlido |
| Grt US Holding, INC. | $59.42 | 2021 | |
| Collegium Pharmaceutical, INC. | $51.95 | 2021-2023 | Belbuca |
| Protega Pharmaceutials INC | $44.80 | 2023 | Roxybond |
| Vertos Medical, INC. | $25.73 | 2023 | Mild Device Kit |
| Averitas Pharma INC. | $22.67 | 2023 | Qutenza |
| Curonix LLC | $16.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Gilbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.